Mangoceuticals acquires mushroom patent for 515k shares; CEO Cohen secures 75.5% voting control of subsidiary M&P

MANGOCEUTICALS, INC.

Acquired mushroom patent WO 2023/086647 from Greenfield Investments for 515,000 restricted shares of common stock.
Contributed substantially all assets (MangoRx Mexico and UK) to new subsidiary Mango & Peaches Corp.
CEO Jacob Cohen received 1.7M common shares (25.4%) and Series A preferred with 51% voting power, totaling 75.5% voting control of M&P.
CEO base salary raised to $360k/year; severance increased to 3x salary plus target bonus; term extended to Dec 2027.
Granted Greenfield a co-exclusive license to patents for 10% royalty on gross sales starting Dec 2025.

item 1.01 item 5.02 item 2.01 item 3.02 item 3.03 item 5.01 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.